A Randomized Double-blind Study to Evaluate the Safety and Efficacy of Denosumab Compared With Zoledronic Acid in Postmenopausal Women With Osteoporosis Previously Treated With Oral Bisphosphonates
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Denosumab (Primary) ; Zoledronic acid
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- Sponsors Amgen
- 06 Jun 2016 Results published in the Journal of Clinical Endocrinology and Metabolism
- 17 Apr 2016 Results presented at the 2016 World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases
- 04 Apr 2016 Results of a sub-study assessing serum intact parathyroid hormone (n=117) presented at The 98th Annual Meeting of the Endocrine Society